Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(18%)
Results Posted
33%(2 trials)

Phase Distribution

Ph not_applicable
9
82%
Ph phase_2
1
9%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
1(10.0%)
N/ANon-phased studies
9(90.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(6)
Other(2)

Detailed Status

Completed6
unknown2
Recruiting2
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (10.0%)
N/A9 (90.0%)

Trials by Status

completed655%
unknown218%
enrolling_by_invitation19%
recruiting218%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
11